Related references
Note: Only part of the references are listed.Nonalcoholic Steatohepatitis Is Associated With Liver-Related Outcomes and All-Cause Mortality in Chronic Hepatitis B
Hannah S. J. Choi et al.
HEPATOLOGY (2020)
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis
Jie Li et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
The Influence of Metabolic Syndrome on the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection in Mainland China
Yifei Tan et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load
Noam Peleg et al.
JHEP REPORTS (2019)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Association Between Hepatic Steatosis, Measured by Controlled Attenuation Parameter, and Fibrosis Burden in Chronic Hepatitis B
Wai-Kay Seto et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Effect of Metabolic Syndrome on the Clinical Outcomes of Chronic Hepatitis B Patients with Nucleos(t)ide Analogues Treatment
Nam Hee Kim et al.
DIGESTIVE DISEASES AND SCIENCES (2018)
Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies
Tracey G. Simon et al.
HEPATOLOGY (2018)
Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million People
Yuanjie Pang et al.
HEPATOLOGY (2018)
Hepatitis B Virus Infection and Decreased Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study
Eun-Jeong Joo et al.
HEPATOLOGY (2017)
Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study
Ming-Whei Yu et al.
GASTROENTEROLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
The epidemiology of non-alcoholic fatty liver disease
Stefano Bellentani
LIVER INTERNATIONAL (2017)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2016)
Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis
Elena Raffetti et al.
LIVER INTERNATIONAL (2016)
Association between hepatitis B and metabolic syndrome: Current state of the art
Peter Jarcuska et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Nonalcoholic Fatty Liver Disease A Systematic Review
Mary E. Rinella
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
Aparna Schweitzer et al.
LANCET (2015)
Hepatitis B Virus Epidemiology
Jennifer H. MacLachlan et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis
Roeland Zoutendijk et al.
GUT (2013)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
Effects of antiviral therapy on preventing liver tumorigenesis and hepatocellular carcinoma recurrence
Zhong-Ming Tan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
The interaction of metabolic factors with HCV infection: Does it matter?
Elisabetta Bugianesi et al.
JOURNAL OF HEPATOLOGY (2012)
Impact of hepatitis B virus infection on metabolic profiles and modifying factors
C. -S. Hsu et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Impact of liver steatosis on response to pegylated interferon therapy in patients with chronic hepatitis B
Fehmi Ates et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
The inverse association of serum HBV DNA level with HDL and adiponectin in chronic hepatitis B infection
Ashraf Mohamadkhani et al.
VIROLOGY JOURNAL (2010)
Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection
Kazuhiko Koike
JOURNAL OF GASTROENTEROLOGY (2009)
Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: A follow-up study in Taiwan
Chi-Ling Chen et al.
GASTROENTEROLOGY (2008)
Body-Mass Index and Progression of Hepatitis B: A Population-Based Cohort Study in Men
Ming-Whei Yu et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Hepatic steatosis has no impact on the outcome of treatment in patients with chronic hepatitis B infection
Mehmet Cindoruk et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2007)
Steatosis in chronic hepatitis C: Why does it really matter?
T Asselah et al.
GUT (2006)
Transient elastography: A new noninvasive method for assessment of hepatic fibrosis
L Sandrin et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2003)
Share Paper
